A Trial of HR19042 Capsule in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2021-07-27
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety and pharmacokinetics of HR19042 capsule
after single administration in healthy Chinese subjects. To explore the pharmacokinetic
characteristics and safety of HR19042 capsule in healthy Chinese subjects.